Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 1,224.00
-10.00 (-0.81%)
Oct 6, 2026, 3:30 PM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 111.84 billion as of October 5, 2026. Its market cap has increased by 26.63% in one year.
Market Cap
111.84B
Enterprise Value
148.50B
Revenue
33.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,224.00
ChartMarket Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 111.84B, an increase of 191.29%. That is a compound annual growth rate of 4.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 111.84B | 49.45% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 217.59B |
| Oncolys BioPharma | 176.32B |
| PeptiDream | 138.34B |
| SanBio Company | 73.45B |
| Heartseed | 59.04B |
| Cuorips | 55.59B |
| 3-D Matrix | 53.75B |
| Healios K.K. | 38.90B |